Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy

被引:110
作者
Szajewska, Hania [1 ]
Setty, Mala
Mrukowicz, Jacek
Guandalini, Stefano
机构
[1] Med Univ Warsaw, Dept Pediat Gastroenterol & Nutr, PL-01184 Warsaw, Poland
[2] Univ Chicago, Dept Pediat, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
[3] Polish Inst Evidence Based Med & Medycyna Praktyc, Krakow, Poland
关键词
live microbial supplements; lactobacill; bifidobacteria;
D O I
10.1097/01.mpg.0000221913.88511.72
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The use of probiotics, once discussed primarily in the context of alternative medicine, is now entering mainstream medicine. However, only a few of the potential health benefits attributed to probiotics have been confirmed in well-designed, well-conducted, randomized, controlled trials. This is especially true in the pediatric Population. We review here the available evidence on efficacy of probiotics in children in the prevention and treatment of gastrointestinal diseases. Although we restrict our analysis to the pediatric age, whenever potentially relevant information is available only from adult studies, they are examined as well. Probiotics have been most extensively studied in the treatment of diarrheal diseases, where their efficacy can be considered well established. Studies documenting effects in other childhood gastrointestinal illnesses are few, although some preliminary results are promising. Furthermore, only a limited number of probiotic strains have been tested, and, as the effects of different probiotic microorganisms are not equivalent, results cannot be generalized. Thus, at present, we have some positive certainties, lots of exciting promises and many unanswered questions.
引用
收藏
页码:454 / 475
页数:22
相关论文
共 157 条
[1]   Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-γ production [J].
Aattouri, N ;
Bouras, M ;
Tome, D ;
Marcos, A ;
Lemonnier, D .
BRITISH JOURNAL OF NUTRITION, 2002, 87 (04) :367-373
[2]   Probiotic bacteria in dietetic products for infants: A commentary by the ESPGHAN Committee on Nutrition [J].
Agostoni, C ;
Axelsson, I ;
Braegger, C ;
Goulet, O ;
Koletzko, B ;
Michaelsen, KF ;
Rigo, J ;
Shamir, R ;
Szajewska, H ;
Turck, D ;
Weaver, LT .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (04) :365-374
[3]  
Andersson H., 2001, Scandinavian Journal of Nutrition/Naringsforskning, V45, P58, DOI 10.1080/11026480410033539
[4]  
[Anonymous], 2003, COCHRANE DATABASE SY
[5]   Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy:: A pilot study [J].
Armuzzi, A ;
Cremonini, F ;
Ojetti, V ;
Bartolozzi, F ;
Canducci, F ;
Candelli, M ;
Santarelli, L ;
Cammarota, G ;
De Lorenzo, A ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
DIGESTION, 2001, 63 (01) :1-7
[6]   The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy [J].
Armuzzi, A ;
Cremonini, F ;
Bartolozzi, F ;
Canducci, F ;
Candelli, M ;
Ojetti, V ;
Cammarota, G ;
Anti, M ;
De Lorenzo, A ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) :163-169
[7]   Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections:: A randomized study [J].
Arvola, T ;
Laiho, K ;
Torkkeli, S ;
Mykkänen, H ;
Salminen, S ;
Maunula, L ;
Isolauri, E .
PEDIATRICS, 1999, 104 (05) :art. no.-e64
[8]  
BALSARI A, 1982, MICROBIOLOGICA, V5, P185
[10]   ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS DUE TO TOXIN-PRODUCING CLOSTRIDIA [J].
BARTLETT, JG ;
CHANG, TW ;
GURWITH, M ;
GORBACH, SL ;
ONDERDONK, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (10) :531-534